Investment
Features
FeesSafety
Academy
More
Pluang+

Strategy's Bitcoin accumulation model faces challenges as market value nears cost basis, shifting focus to financial sustainability.

Market News
19 Jul 2026
AMBCrypto
View Source
Neutral
pluang ai news

Strategy, holding 843,775 BTC valued at $54.5 billion but with a $63.69 billion cost basis, is facing pressure as the market value of its Bitcoin treasury nears its purchase cost. This reduces the premium that allowed it to fund Bitcoin purchases through equity issuance, forcing a shift from aggressive accumulation to maintaining financial flexibility. The company now must balance dividend obligations, convertible notes, and limited revenue, raising concerns about its ability to sustain future Bitcoin purchases without diluting shareholder value. The debate highlights a broader challenge for Bitcoin treasury firms: growth depends not just on accumulation but on resilient capital structures amid market volatility.

More News

Scotiabank raises Palo Alto Networks price target to $430 after strong Q3 and growth outlook.

Scotiabank raises Palo Alto Networks price target to $430 after strong Q3 and growth outlook.

Scotiabank increased its price target for Palo Alto Networks to $430, suggesting a 13% upside from current levels, following a 30% surge in shares after strong Q3 results. The cybersecurity firm is expected to deliver robust Q4 performance and signif...

Analyst Insights
Bullish
2 hours ago
Fiserv stock downgraded amid lowered 2026 growth and profit forecasts, with shares expected to drop nearly 17%.

Fiserv stock downgraded amid lowered 2026 growth and profit forecasts, with shares expected to drop nearly 17%.

Fiserv faces a downgrade from Cantor Fitzgerald with a new price target of $53, down nearly 17% from its recent price of $63.80. The company cut its 2026 guidance, expecting flat to slightly negative organic growth and a 14.2% drop in earnings per sh...

Analyst Insights
Bearish
3 hours ago
BioMarin Pharma gains with analyst upgrade, patent deal, and $275M acquisition boosting growth.

BioMarin Pharma gains with analyst upgrade, patent deal, and $275M acquisition boosting growth.

BioMarin Pharmaceutical Inc. saw its stock gain momentum after Jefferies raised its price target to $105, signaling strong confidence in the biotech firm. The company secured new revenue streams through a patent settlement with Ascendis Pharma, earni...

Analyst Insights
Bullish
4 hours ago
Aehr Test Systems CEO sells $5.2M shares after stock price jumps 564%.

Aehr Test Systems CEO sells $5.2M shares after stock price jumps 564%.

Aehr Test Systems' CEO sold shares worth $5.2 million following a remarkable 564% increase in the company's stock price. This significant sale highlights the CEO capitalizing on the stock's strong rally. Investors may view this move as a signal about...

Market News
Neutral
4 hours ago
Gold dips slightly while silver rises amid U.S.-Iran tensions and rising oil prices.

Gold dips slightly while silver rises amid U.S.-Iran tensions and rising oil prices.

Spot gold prices fell slightly to around $4,446.50 an ounce, pressured by rising U.S. Treasury yields and higher oil prices following renewed U.S.-Iran military tensions. Silver edged up modestly to $66.36 an ounce. The geopolitical conflict near the...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App